Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pendopharm
Montreal, Quebec, Canadapendopharm.com ↗
- Ownership
- Private
- Employees
- ~48
- Development stage
- Commercial
01
Overview
Pendopharm commercializes more than 40 specialty pharmaceutical products in Canada. The company focuses on both branded and established medicines across several therapeutic areas. It actively licenses and partners to bring innovative treatments to market. Recent activities include investment in Edesa Biotech and licensing novel anorectal treatments for the Canadian market. Clinical results for specific programs are not detailed publicly.
- Therapeutic areas
- OtherGastroenterologyImmunologyInfectious Diseases
- Modalities
- Small moleculesprescription medicinesover-the-counter (OTC) products
- Industry
- Biotech
02
Partnerships
Edesa Biotech Inc. – investment and product licensing partnership
Beyond the preview
Go deeper on Pendopharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pendopharm.